Eli Lilly's Mounjaro has overtaken Keytruda to become the world's top-selling medicine. Its rise highlights booming demand ...

Mounjaro generated $8.7 billion for Lilly in the first quarter of 2026, outperforming Merck's Keytruda, which posted sales of ...

Eli Lilly & Co.’s blockbuster diabetes drug Mounjaro has surpassed Merck & Co.’s cancer therapy Keytruda as the world’s ...

The Gibraltar Health Authority has begun using the subcutaneous form of Pembrolizumab for the treatment of some cancers, with ...

Dividend income arrives whether markets rally or sell off. For investors seeking recurring cash flow, high-yield equities ...

With an upside potential of 21.26% as of May 3, Merck & Co., Inc. (NYSE:MRK) is included among the 10 Best Fortune 500 Stocks ...

'It’ll be much better for patients who will be free to get on with their lives instead of spending so much time in hospital' ...

Severe shortage of commercial LNG supply has put glass bottle manufacturers under significant strain, and they too face ...

Asian equities climbed to a record as optimism grew that the US and Iran were nearing a deal to end the conflict that had ...

Zydus Lifesciences Limited has informed that its wholly owned subsidiary, Zydus VTEC Limited (ZVTEC), has received a demand ...

Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...